Byrnes Michael has bought 4,863 shares of Effector Therapeutics, Inc. [EFTR] at $0.46 a share.
Effector Therapeutics, Inc. [EFTR] disclosed in an SEC Form 4 submission Monday, May 15, 2023 that the deal increased Byrnes Michael's holding in the company to 38,747.
Effector Therapeutics, Inc. [EFTR] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.